ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Dupilumab for patients with allergic fungal rhinosinusitis

Study limitation reported by the research below: “Total sample size is very small (N=62), which may limit the robustness of subgroup findings, including the comorbid asthma analysis.”

Papers